Vicky Kritikos

2.3k total citations
57 papers, 861 citations indexed

About

Vicky Kritikos is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Immunology and Allergy. According to data from OpenAlex, Vicky Kritikos has authored 57 papers receiving a total of 861 indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Physiology, 27 papers in Pulmonary and Respiratory Medicine and 20 papers in Immunology and Allergy. Recurrent topics in Vicky Kritikos's work include Asthma and respiratory diseases (45 papers), Allergic Rhinitis and Sensitization (20 papers) and Respiratory and Cough-Related Research (18 papers). Vicky Kritikos is often cited by papers focused on Asthma and respiratory diseases (45 papers), Allergic Rhinitis and Sensitization (20 papers) and Respiratory and Cough-Related Research (18 papers). Vicky Kritikos collaborates with scholars based in Australia, United Kingdom and Singapore. Vicky Kritikos's co-authors include Sinthia Bosnic‐Anticevich, Biljana Cvetkovski, David Price, Kwok Yan, Rachel Tan, Bandana Saini, Carol Armour, Ines Krass, Rebekah Moles and Helen K. Reddel and has published in prestigious journals such as SHILAP Revista de lepidopterología, European Respiratory Journal and Allergy.

In The Last Decade

Vicky Kritikos

56 papers receiving 820 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vicky Kritikos Australia 18 595 385 230 160 88 57 861
Cristina Gonçalves Alvim Brazil 12 264 0.4× 228 0.6× 46 0.2× 110 0.7× 50 0.6× 41 507
Martin E. Hurwitz United States 9 227 0.4× 215 0.6× 21 0.1× 226 1.4× 74 0.8× 13 623
Mac Cochrane United Kingdom 8 285 0.5× 272 0.7× 20 0.1× 100 0.6× 163 1.9× 11 538
R Ampon Australia 12 348 0.6× 226 0.6× 134 0.6× 46 0.3× 54 0.6× 24 592
Maria do Patrocínio Tenório Nunes Brazil 14 252 0.4× 253 0.7× 15 0.1× 89 0.6× 125 1.4× 41 583
Sue‐Hsien Chen Taiwan 12 130 0.2× 70 0.2× 30 0.1× 85 0.5× 60 0.7× 22 339
Heather Sharpe Canada 11 277 0.5× 206 0.5× 11 0.0× 112 0.7× 33 0.4× 37 469
Margee Louisias United States 8 136 0.2× 59 0.2× 66 0.3× 89 0.6× 42 0.5× 22 368
Linda Gibson‐Young United States 12 263 0.4× 135 0.4× 12 0.1× 102 0.6× 53 0.6× 33 516
Hani Salim Malaysia 11 149 0.3× 79 0.2× 24 0.1× 174 1.1× 28 0.3× 36 437

Countries citing papers authored by Vicky Kritikos

Since Specialization
Citations

This map shows the geographic impact of Vicky Kritikos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vicky Kritikos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vicky Kritikos more than expected).

Fields of papers citing papers by Vicky Kritikos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vicky Kritikos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vicky Kritikos. The network helps show where Vicky Kritikos may publish in the future.

Co-authorship network of co-authors of Vicky Kritikos

This figure shows the co-authorship network connecting the top 25 collaborators of Vicky Kritikos. A scholar is included among the top collaborators of Vicky Kritikos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vicky Kritikos. Vicky Kritikos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hamada, Yuto, Dennis Thomas, Vanessa M. McDonald, et al.. (2025). Impact of clinical remission on quality of life in severe eosinophilic asthma treated with mepolizumab. Annals of Allergy Asthma & Immunology. 135(5). 537–546.e12. 2 indexed citations
2.
Hamada, Yuto, Dennis Thomas, Erin S. Harvey, et al.. (2024). Distinct trajectories of treatment response to mepolizumab toward remission in patients with severe eosinophilic asthma. European Respiratory Journal. 65(1). 2400782–2400782. 5 indexed citations
3.
Hamada, Yuto, Peter G. Gibson, Erin S. Harvey, et al.. (2024). Early Treatment Response to Mepolizumab Predicts Clinical Remission in Severe Eosinophilic Asthma. The Journal of Allergy and Clinical Immunology In Practice. 13(2). 333–342.e9. 3 indexed citations
4.
Cvetkovski, Biljana, et al.. (2023). Uncovering the Burden of Rhinitis in Patients Purchasing Nonprescription Short-Acting β-Agonist (SABA) in the Community. SHILAP Revista de lepidopterología. 11(4). 115–115. 2 indexed citations
5.
Kritikos, Vicky, Biljana Cvetkovski, Janet Rimmer, et al.. (2023). The impact of implementing an allergic rhinitis clinical management pathway (AR-CMaP) in the community pharmacy. SHILAP Revista de lepidopterología. 12. 100340–100340. 1 indexed citations
6.
Kritikos, Vicky, Erin S. Harvey, Sean Stevens, et al.. (2022). Comorbidities Modify the Phenotype but Not the Treatment Effectiveness to Mepolizumab in Severe Eosinophilic Asthma. The Journal of Allergy and Clinical Immunology In Practice. 11(3). 885–895.e13. 7 indexed citations
7.
Cvetkovski, Biljana, et al.. (2022). Exploring General Practitioners’ Preferences and Experience with Respiratory Inhaler Devices. Pulmonary Therapy. 8(3). 283–296. 1 indexed citations
8.
Kritikos, Vicky, David Price, Alberto Papi, et al.. (2020). <p>The Burden of Self-Reported Rhinitis and Associated Risk for Exacerbations with Moderate-Severe Asthma in Primary Care Patients</p>. Journal of Asthma and Allergy. Volume 13. 415–428. 9 indexed citations
10.
Cvetkovski, Biljana, et al.. (2019). Exploring the Asthma Network in People with Allergic Rhinitis Utilizing an Egocentric Social Network Analysis. Pulmonary Therapy. 5(2). 235–245. 3 indexed citations
11.
Cvetkovski, Biljana, et al.. (2019). A qualitative investigation of the allergic rhinitis network from the perspective of the patient. npj Primary Care Respiratory Medicine. 29(1). 35–35. 14 indexed citations
12.
Cvetkovski, Biljana, Vicky Kritikos, Kwok Yan, & Sinthia Bosnic‐Anticevich. (2018). Tell me about your hay fever: a qualitative investigation of allergic rhinitis management from the perspective of the patient. npj Primary Care Respiratory Medicine. 28(1). 3–3. 29 indexed citations
13.
Cvetkovski, Biljana, et al.. (2018). A patient-centric analysis to identify key influences in allergic rhinitis management. npj Primary Care Respiratory Medicine. 28(1). 34–34. 16 indexed citations
15.
Tan, Rachel, Biljana Cvetkovski, Vicky Kritikos, et al.. (2018). The Burden of Rhinitis and the Impact of Medication Management within the Community Pharmacy Setting. The Journal of Allergy and Clinical Immunology In Practice. 6(5). 1717–1725. 24 indexed citations
16.
Carney, A. Simon, David Price, Peter Smith, et al.. (2017). Seasonal patterns of oral antihistamine and intranasal corticosteroid purchases from Australian community pharmacies: a retrospective observational study. PubMed. Volume 8. 157–165. 2 indexed citations
17.
Kritikos, Vicky, et al.. (2017). Inhaler technique: does age matter? A systematic review. European Respiratory Review. 26(146). 170055–170055. 49 indexed citations
18.
Kritikos, Vicky, et al.. (2017). Development and validation of an asthma first aid knowledge questionnaire. Research in Social and Administrative Pharmacy. 14(5). 459–463. 8 indexed citations
19.
Kritikos, Vicky, et al.. (2011). Intergroup Peer Assessment in Problem-Based Learning Tutorials for Undergraduate Pharmacy Students. American Journal of Pharmaceutical Education. 75(4). 73–73. 43 indexed citations
20.
Kritikos, Vicky, Carol Armour, & Sinthia Bosnic‐Anticevich. (2007). Interactive Small-Group Asthma Education in the Community Pharmacy Setting: A Pilot Study. Journal of Asthma. 44(1). 57–64. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026